ConductScience.org, home

Paper3099861

Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60.

Hemmi H and 1 other. Blood, 1987. Cited by 121 papers, by iCite.

Cite this record

ConductScience Library. Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Papers, record 3099861. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3099861

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60.
PubMed
Journal
Blood
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
3.01
iCite
Revised in PubMed
2021-02-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hemmi HH
2Breitman TRT R

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell DifferentiationMajor topic
Interferon-gammaMajor topic
TretinoinMajor topic
Cell Line
Drug Synergism
Humans
Leukemia, Myeloid, Acute
Recombinant Proteins

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
21566745GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.Transl Oncogenomics2008https://conductscience.org/library/papers/21566745PubMed
21274002Interferon-α in acute myeloid leukemia: an old drug revisited.Leukemia2011https://conductscience.org/library/papers/21274002PubMed
20382543Cytokine-induced tumor suppressors: a GRIM story.Cytokine2010https://conductscience.org/library/papers/20382543PubMed
11429056Synergistic effects of highly unsaturated fatty acid-containing phosphatidyl-ethanolamine on differentiation of human leukemia HL-60 cells by dibutyryl cyclic adenosine monophosphate.Jpn J Cancer Res2001https://conductscience.org/library/papers/11429056PubMed
10815802All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells.Oncogene2000https://conductscience.org/library/papers/10815802PubMed
9547674An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.Invest New Drugs1997https://conductscience.org/library/papers/9547674PubMed
9207104Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9207104PubMed
8774361HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.Immunology1996https://conductscience.org/library/papers/8774361PubMed
8349437Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.Invest New Drugs1993https://conductscience.org/library/papers/8349437PubMed
3037549Cannabinoids induce incomplete maturation of cultured human leukemia cells.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3037549PubMed
2672599Myelodysplastic syndromes.West J Med1989https://conductscience.org/library/papers/2672599PubMed
2492972Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages.Infect Immun1989https://conductscience.org/library/papers/2492972PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
NT5E4907PubTator's text mininghttps://conductscience.org/library/genes/4907NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3099861

GET https://conductscience.org/api/papers/v1/3099861/authors